These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22827224)

  • 1. mRNA as a versatile tool for exogenous protein expression.
    Kuhn AN; Beiβert T; Simon P; Vallazza B; Buck J; Davies BP; Tureci O; Sahin U
    Curr Gene Ther; 2012 Oct; 12(5):347-61. PubMed ID: 22827224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.
    Vallazza B; Petri S; Poleganov MA; Eberle F; Kuhn AN; Sahin U
    Wiley Interdiscip Rev RNA; 2015; 6(5):471-99. PubMed ID: 26061157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences.
    Rhoads RE
    Methods Mol Biol; 2016; 1428():3-27. PubMed ID: 27236789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.
    Orlandini von Niessen AG; Poleganov MA; Rechner C; Plaschke A; Kranz LM; Fesser S; Diken M; Löwer M; Vallazza B; Beissert T; Bukur V; Kuhn AN; Türeci Ö; Sahin U
    Mol Ther; 2019 Apr; 27(4):824-836. PubMed ID: 30638957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new developing class of gene delivery: messenger RNA-based therapeutics.
    Meng Z; O'Keeffe-Ahern J; Lyu J; Pierucci L; Zhou D; Wang W
    Biomater Sci; 2017 Nov; 5(12):2381-2392. PubMed ID: 29063914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate enhancement of transgene transcription and translation in a lentiviral vector.
    Yilmaz A; Fernandez S; Lairmore MD; Boris-Lawrie K
    Retrovirology; 2006 Feb; 3():13. PubMed ID: 16480517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current prospects for mRNA gene delivery.
    Yamamoto A; Kormann M; Rosenecker J; Rudolph C
    Eur J Pharm Biopharm; 2009 Mar; 71(3):484-9. PubMed ID: 18948192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vector design for optimal protein expression.
    van der Velden AW; Voorma HO; Thomas AA
    Biotechniques; 2001 Sep; 31(3):572, 574, 576-80, passim. PubMed ID: 11570501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved translation efficiency of therapeutic mRNA.
    Zarghampoor F; Azarpira N; Khatami SR; Behzad-Behbahani A; Foroughmand AM
    Gene; 2019 Jul; 707():231-238. PubMed ID: 31063797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-fused expression of HAb18GEF by reducing stability of translational initiation region in mRNA].
    Zhang SH; Xing JL; Yao XY; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):175-80. PubMed ID: 15969104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere J; Dewitte H; De Smedt SC; Remaut K
    Drug Discov Today; 2016 Jan; 21(1):11-25. PubMed ID: 26210957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in RNA-based strategies for cancer gene therapy.
    Bettinger T; Read ML
    Curr Opin Mol Ther; 2001 Apr; 3(2):116-24. PubMed ID: 11338923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.
    Oh S; Kessler JA
    Methods; 2018 Jan; 133():29-43. PubMed ID: 29080741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA Expression.
    Jiang X; Yu H; Teo CR; Tan GS; Goh SC; Patel P; Chua YK; Hameed NB; Bertoletti A; Patzel V
    Mol Ther; 2016 Sep; 24(9):1581-91. PubMed ID: 27357627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.
    Youn H; Chung JK
    Expert Opin Biol Ther; 2015; 15(9):1337-48. PubMed ID: 26125492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
    Shimizu K; Sakurai F; Tachibana M; Mizuguchi H
    Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating gene expression in stem cells without recombinant DNA and permanent genetic modification.
    Heng BC; Hong YH; Cao T
    Cell Tissue Res; 2005 Aug; 321(2):147-50. PubMed ID: 15942773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.